The researchers are aiming to find molecular signatures in blood that identify previous exposures to materials associated with weapons of mass destruction.
The projects, set to begin this year, concern prostate cancer, infectious diseases, rheumatoid arthritis, inflammatory bowel disease, heart disease, and sleep disorders.
Geisinger will use the funding to develop genomic-based approaches for detecting arrhythmogenic right ventricular cardiomyopathy to aid in early intervention.
The Polish company recently received 9 million Polish złoty ($2.4 million) from the country's National Center for Research and Development to support its activities.
The UK informatics startup has received funding from Innovate UK to implement an informatics platform for physicians to identify patients for genomic testing.
Two patients fell ill, and one subsequently died, following a fecal microbiome transplant that harbored multi-drug-resistant bacteria, according to the New York Times.
